Delivery Order SPE2DR25D1103-SPE2DR26FE122
Award Date 11/28/25
Potential Completion Date 12/1/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,450.45 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 80mg, a prescription biologic medication used to treat Crohn's disease, ulcerative colitis, and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 10, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,953.33 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication used to treat autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and was awarded on a competitive, non-set-aside basis. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,989.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune and inflammatory conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) CF Pen 40 mg/0.4 ml, a biologic medication used to treat autoimmune conditions. The contract, valued at $2,387.88 with a firm fixed price, was competitively awarded without set-aside designation and is scheduled for completion by December 18, 2025. AmerisourceBergen will fulfill this order from its facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,907.87 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 80 mg/0.8 mL, a biologic immunosuppressant medication commonly used to treat autoimmune conditions. This firm fixed-price delivery order was awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive,...
- The Defense Logistics Agency awarded a delivery order valued at $9,416.16 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune and inflammatory conditions. This firm fixed price, non-set-aside delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) pen formulations in 80 mg doses for the treatment of Crohn's disease and ulcerative colitis, with a ceiling value of $1,132.95. The contract, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, utilized firm fixed-price pricing and was not set-aside. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is...
- The Defense Logistics Agency awarded a $1,132.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune inflammatory conditions. The delivery order, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, was issued without a set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $37,698.62 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic pharmaceutical used to treat autoimmune conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of May 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $2,022.32 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic medication commonly used to treat autoimmune and inflammatory conditions. This competitively awarded, firm fixed-price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...